drugset / Trial / NCT00006001
SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of SU5416 in treating patients who have metastatic or locally recurrent colorectal cancer. SU5416 may stop the growth of colorectal cancer by stopping blood flow to the tumor.
Timeline
- Start
- 2000-08
- Primary completion
- 2007-02
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | semaxanib | Small molecule | — | Intravenous |